Authors: Shintaku DN, Lopes MA, Beraldo RF, Oliveira ECS, Herrerias GSP, Oliveira ACB, Baima JP, Barbosa WF, Silva GF, Sassaki LY.
DOI: 10.1590/1414-431x2025e14523
Abstract Summary
Study reveals 42% of inflammatory bowel disease (IBD) patients in Brazil have non-alcoholic fatty liver disease (NAFLD), the most common liver complication. Among 138 IBD patients screened by ultrasound, liver abnormalities correlated with elevated liver enzymes and metabolic markers. Researchers recommend routine liver screening in IBD patients for early intervention to prevent cirrhosis.
Why Brain? ๐ง
IBD patients show high prevalence of liver disease, particularly NAFLD (42%), highlighting need for routine liver screening to prevent progression to cirrhosis and enable early intervention.
Study Limitations:
Single-center study
Cross-sectional design
License: cc by.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
